TETRALOGIC PHARMACEUTICALS Corp Watch

from S-3 51 pages TETRALOGIC PHARMACEUTICALS Corporation as the Company and U.S. Bank National Association as Trustee Indenture Dated as of ,

from 8-K 13 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company, a New York Corporation (“Dtc”), to the Company or Its Agent for Registration of Transfer, Exchange, or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or in Such Other Name as Is Requested by an Authorized Representative of Dtc (And Any Payment Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge, or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Inasmuch as the Registered Owner Hereof, Cede & Co., Has an Interest Herein

from 8-K 107 pages TETRALOGIC PHARMACEUTICALS Corporation as Issuer 8.00% Convertible Senior Notes Due 2019 Indenture Dated as of June 23, 2014 U.S. Bank National Association as Trustee

from S-8 22 pages TETRALOGIC Pharmaceutical Corporation Amended and Restated 2013 Equity Incentive Plan

from S-8 29 pages TETRALOGIC PHARMACEUTICALS Corporation 2004 Equity Incentive Plan

from S-1/A 2 pages Amendment No. 1 to Warrant to Purchase Equity Securities of TETRALOGIC PHARMACEUTICALS Corporation

from S-1/A 2 pages Incorporated Under the Laws of the State of Delaware Incorporated Under the Laws of the State of Delaware Common Stock Fully Paid and Non-Assessable Shares of Common Stock, $0.0001 Par Value, of TETRALOGIC PHARMACEUTICALS Corporation Transferable on the Books of the Corporation by the Holder Hereof in Person or by Attorney Upon Surrender of This Certificate Properly Endorsed. This Certificate Is Not Valid Until Countersigned and Registered by the Transfer Agent and Registrar. in Witness Whereof, the Said Corporation Has Caused This Certificate to Be Signed by Facsimile Signatures of Its Duly Authorized Officers Dated: President and Chief Executive Officer Chief Financial Officer and Secretary

from S-1/A 8 pages TETRALOGIC PHARMACEUTICALS Corporation Unsecured Convertible Promissory Note

from S-1/A 12 pages TETRALOGIC PHARMACEUTICALS Corporation Warrant to Purchase Equity Securities

from S-1 24 pages Second Amended and Restated Right of First Refusal and Co-Sale Agreement

from S-1 29 pages Second Amended and Restated Voting Agreement

from S-1 17 pages TETRALOGIC PHARMACEUTICALS Corporation Note Purchase Agreement TETRALOGIC PHARMACEUTICALS Corporation Note Purchase Agreement

from S-1 8 pages TETRALOGIC PHARMACEUTICALS Corporation Unsecured Convertible Promissory Note

from S-1 18 pages TETRALOGIC PHARMACEUTICALS Corporation Unsecured Convertible Promissory Note

from S-1 12 pages TETRALOGIC PHARMACEUTICALS Corporation Warrant to Purchase Equity Securities

from S-1 12 pages TETRALOGIC PHARMACEUTICALS Corporation Warrant to Purchase Equity Securities

from S-1 12 pages Void After 5:00 P.M. New York Time on the Expiration Date (As Defined Below) Warrant to Purchase Shares of Common Stock

from S-1 11 pages Void After 5:00 P.M. New York Time on the Expiration Date (As Defined Below) Warrant to Purchase Shares of Common Stock

from S-1 12 pages Void After 5:00 P.M. New York Time on the Expiration Date (As Defined Below) Warrant to Purchase Shares of Convertible Preferred Stock

from S-1 12 pages Void After 5:00 P.M. New York Time on the Expiration Date (As Defined Below) Warrant to Purchase Shares of Convertible Preferred Stock